Vaxneuvance
RxNorm 2566418

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2566418 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Vaxneuvance.

The following semantic concepts and normalized strings are associated with this clinical entity:

BN
Vaxneuvance
AUI:12676011
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

BNPrescribable

Brand Name (BN):
Vaxneuvance
(Atom ID: 12676011)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Vaxneuvance
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2566418
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12676011
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
BN
Brand Name (A proprietary name for a family of products containing a specific active ingredient.)
Source Code
2566418
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN BN CARDINALITY
multi
Cardinality of RxNorm Brand Name Atom

Patient Education

Pneumococcal Conjugate Vaccine (PCV13)


Why get vaccinated? Pneumococcal vaccination can protect both children and adults from pneumococcal disease. Pneumococcal disease is caused by bacteria that can spread from person to person through close contact. It can cause ear infections, and it can also lead to more serious infections of the: Lungs (pneumonia) Blood (bacteremia) Covering of the brain and spinal cord (meningitis). Pneumococcal pneumonia is most common among adults. Pneumococcal meningitis can cause deafness and brain damage, and it kills about 1 child in 10 who get it. Anyone can get pneumococcal disease, but children under 2 years of age and adults 65 years and older, people with certain medical conditions, and cigarette smokers are at the highest risk. Before there was a vaccine, pneumococcal infections caused many problems each year in the United States in children younger than 5, including: more than 700 cases of meningitis, about 13,000 blood infections, about 5 million ear infections, and about 200 deaths. Since the vaccine became available, severe pneumococcal disease in these children has fallen by 88%. About 18,000 older adults die of pneumococcal disease each year in the United States. Treatment of pneumococcal infections with penicillin and other drugs is not as effective as it used to be, because some strains are resistant to these drugs. This makes prevention through vaccination even more important.
[Learn More]


* Please review the disclaimer below.